Latest Articles
Cartherics and Zucker Institute execute research collaboration and option agreement to combine iPSC-derived NK cell platform with novel anti-tissue factor antibody – News Hub - Medianet News Hub
Cartherics and Zucker Institute execute research collaboration and option agreement to combine iPSC-derived NK cell platform with novel anti-tissue factor antibody – News Hub Medianet News Hub
Published: Sept. 1, 2026, 12:29 a.m.
Cartherics and Zucker Institute execute research collaboration and option agreement to combine iPSC-derived NK cell platform with novel anti-tissue factor antibody – News Hub - newshub.medianet.com.au
Cartherics and Zucker Institute execute research collaboration and option agreement to combine iPSC-derived NK cell platform with novel anti-tissue factor antibody – News Hub newshub.medianet.com.au
Published: Sept. 1, 2026, 12:29 a.m.
Link copied to clipboard!